研发新冠疫苗的BioNTech和莫德纳均收跌超7%，BioNTech的疫苗合作方辉瑞跌近4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。美东时间12日周五，媒体爆出，特朗普政府将多名儿童死亡的原因与注射新冠疫苗挂钩，并考虑限制疫苗接种范围。上述消息引发投资者关注，市场担忧情绪迅速蔓延至整个生物科技板块，投资者...
Source Link研发新冠疫苗的BioNTech和莫德纳均收跌超7%，BioNTech的疫苗合作方辉瑞跌近4%。投资者担心，如果特朗普政府进一步收紧疫苗接种政策，可能对疫苗制造商的业务造成重大冲击，特别是对莫德纳这类高度依赖新冠疫苗收入的公司。美东时间12日周五，媒体爆出，特朗普政府将多名儿童死亡的原因与注射新冠疫苗挂钩，并考虑限制疫苗接种范围。上述消息引发投资者关注，市场担忧情绪迅速蔓延至整个生物科技板块，投资者...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.